Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / First Turn Management, LLC
Form 13F · Q2 2026

First Turn Management, LLC

CIK 1993440Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$935M
Reported book value
31
Positions
11
Quarters on record
Top 50
Positions

First Turn Management, LLC — holdings

Top 31 positions of 31, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1RVMD Revolution Medicines Inc415,307−11.3%$78M8.3%
2ABIVAX SA Abivax Sa489,889+5.2%$65M7.0%
3AXSM Axsome Therapeutics Inc.218,415+15.7%$53M5.7%
4ELVN Enliven Therapeutics Inc954,360+53.0%$48M5.2%
5BBIO Bridgebio Pharma Inc633,364−9.0%$47M5.0%
6ROIV Roivant Sciences Ltd1.3M+11.8%$47M5.0%
7UTHR United Therapeutics Corp Del84,932−18.9%$46M4.9%
8CYTK Cytokinetics Inc527,412+85.9%$45M4.8%
9XENE Xenon Pharmaceuticals Inc600,200−23.7%$36M3.9%
10CELC Celcuity Inc329,101+56.3%$34M3.7%
11VRDN Viridian Therapeutics Inc1.7M+83.2%$31M3.3%
12INSM Insmed Inc263,851+6.2%$28M3.0%
13UNIQURE NV Uniqure Nv608,925−1.1%$28M3.0%
14ASND Ascendis Pharma A/S104,877—$28M3.0%
15PRAX Praxis Precision Medicines I83,528+96.8%$28M3.0%
16DNTH Dianthus Therapeutics Inc285,771+29.4%$28M3.0%
17PCVX Vaxcyte Inc443,836—$26M2.8%
18MIRM Mirum Pharmaceuticals Inc218,051−45.6%$26M2.7%
19PVLA Palvella Therapeutics Inc Ne156,450+5.6%$24M2.6%
20COGT Cogent Biosciences Inc602,281−36.4%$23M2.5%
21ERAS Erasca Inc1.2M+40.8%$22M2.4%
22ORIC Oric Pharmaceuticals Inc2.0M+0.0%$22M2.3%
23NAMS Newamsterdam Pharma Company582,497+4.3%$20M2.1%
24APOGEE THERAPEUTICS INC Apogee Therapeutics Inc138,822−73.0%$18M2.0%
25RYTM Rhythm Pharmaceuticals Inc154,018—$17M1.8%
26INBX Inhibrx Biosciences Inc164,783—$16M1.7%
27SRRK Scholar Rock Hldg Corp271,227−39.2%$15M1.6%
28ORKA Oruka Therapeutics Inc155,343—$15M1.6%
29KYMR Kymera Therapeutics Inc102,533−59.7%$12M1.3%
30SION Sionna Therapeutics Inc110,493—$5M0.5%
31NUVALENT INC Nuvalent Inc26,298−92.9%$3M0.3%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.